Junel Fe Kit
Product Images NDC 0093-5328

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Junel Fe (NDC 0093-5328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol Image (Image 1)

Ethinyl Estradiol Image (Image 1)
A forest plot chart showing effect estimates (Odds Ratios/Relative Risks) with 95% confidence intervals from various studies related to contraceptive use. Studies are listed by name and year on the left, effect estimates with confidence intervals on the right, and the central plot displays the estimates on a horizontal axis ranging from -1.5 to 2.0. The chart compares 'Ever use' and 'Current use' data from multiple women’s health studies.*
FDA Label Image

Norethindrone Acetate Image (Image 2)

Norethindrone Acetate Image (Image 2)
Chemical structure of the active ingredient, Ethinyl Estradiol, showing its molecular framework with hydroxyl groups and an ethynyl substituent.*
FDA Label Image

Figure 1 (Image 3)

Figure 1 (Image 3)
Chemical structure of Norethindrone Acetate, one of the active ingredients in Junel Fe 24, shown as a molecular diagram with carbon rings and functional groups including acetoxy and alkyne moieties.*
FDA Label Image

Figure 2 (Image 4)

Figure 2 (Image 4)
A pharmacokinetic graph showing Norethindrone concentration (pg/mL) over time (hours) on Day 1 and Day 24. The chart displays two curves: one solid line for Day 1 and one dotted line for Day 24, illustrating the change in drug concentration over a 60-hour period.*
FDA Label Image

Fewer More Pregnancies (Image 5)

Fewer More Pregnancies (Image 5)
A pharmacokinetic line graph showing ethinyl estradiol concentration (pg/mL) over time (hours). Two curves compare Day 1 and Day 24 concentrations, with Day 24 showing a higher and more prolonged concentration than Day 1 across a 60-hour period.*
FDA Label Image

Figure A (Image 6)

Figure A (Image 6)
A vertical chart comparing different birth control methods by pregnancy rates per 100 women per year, ranging from fewer than 1 pregnancy to 85 or more. It categorizes methods including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, condoms, diaphragm, behavioral methods, spermicides, withdrawal, and no birth control, indicating their relative effectiveness in reducing pregnancies.*
FDA Label Image

Image (Image 7)

Image (Image 7)
Diagram of Junel Fe 24 oral contraceptive kit showing a 28-day pill pack with four rows for weeks 1 through 4 and columns for days Sunday through Saturday. Arrows and instructions guide the user to start on Sunday or the first day of their period, taking pills left to right each week. The pack indicates the active drug names and dosage strength.*
FDA Label Image

Image (Image 8)

Image (Image 8)
Junel Fe 24 kit containing norethindrone acetate and ethinyl estradiol tablets USP 1 mg/0.02 mg and ferrous fumarate tablets. Pack displays three blister cards with 28 tablets total, manufactured by Teva Pharmaceuticals USA, Inc. Label includes dosing instructions, storage conditions, and a barcode. Packaging is beige and olive green with blue text.*
FDA Label Image

Image 9

Image 9
Junel Fe 24 kit packaging label containing norethindrone acetate and ethinyl estradiol tablets USP 1 mg/0.02 mg with ferrous fumarate tablets. The label indicates three blister cards of 28 tablets each, manufactured by Teva Pharmaceuticals USA, Inc. The packaging is marked with NDC 0093-5328-62 and includes barcode and usage instructions area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.